R. Fallat

1.7k total citations
34 papers, 1.3k citations indexed

About

R. Fallat is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, R. Fallat has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Surgery and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in R. Fallat's work include Lipoproteins and Cardiovascular Health (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and Lipid metabolism and disorders (14 papers). R. Fallat is often cited by papers focused on Lipoproteins and Cardiovascular Health (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and Lipid metabolism and disorders (14 papers). R. Fallat collaborates with scholars based in United States and Australia. R. Fallat's co-authors include Charles J. Glueck, Peter S. Gartside, P M Steiner, Richard Tsang, Robert C. Elston, Janusz Sielski, Reginald C. Tsang, Rodney C.P. Go, R C Tsang and Margot J. Mellies and has published in prestigious journals such as JAMA, PEDIATRICS and American Journal of Obstetrics and Gynecology.

In The Last Decade

R. Fallat

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Fallat United States 20 697 655 352 225 207 34 1.3k
P M Steiner United States 18 737 1.1× 556 0.8× 293 0.8× 121 0.5× 197 1.0× 47 1.3k
E Nikkilä Finland 19 757 1.1× 446 0.7× 360 1.0× 197 0.9× 141 0.7× 36 1.4k
Joanne Hoover United States 15 874 1.3× 409 0.6× 244 0.7× 223 1.0× 145 0.7× 21 1.4k
D. Adlersberg United States 23 297 0.4× 466 0.7× 189 0.5× 165 0.7× 93 0.4× 84 1.4k
Tiina Solakivi Finland 20 396 0.6× 397 0.6× 349 1.0× 116 0.5× 196 0.9× 44 1.5k
Hans Jansen Netherlands 27 1.1k 1.6× 853 1.3× 707 2.0× 237 1.1× 299 1.4× 60 2.0k
Bernard M. Wolfe Canada 15 501 0.7× 331 0.5× 565 1.6× 76 0.3× 70 0.3× 25 1.2k
M Dobiášová Czechia 18 552 0.8× 449 0.7× 252 0.7× 34 0.2× 139 0.7× 55 1.1k
Maurice A. Mishkel Canada 14 355 0.5× 312 0.5× 222 0.6× 51 0.2× 110 0.5× 21 930
D. Wile United Kingdom 14 464 0.7× 424 0.6× 132 0.4× 128 0.6× 71 0.3× 20 1.0k

Countries citing papers authored by R. Fallat

Since Specialization
Citations

This map shows the geographic impact of R. Fallat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Fallat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Fallat more than expected).

Fields of papers citing papers by R. Fallat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Fallat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Fallat. The network helps show where R. Fallat may publish in the future.

Co-authorship network of co-authors of R. Fallat

This figure shows the co-authorship network connecting the top 25 collaborators of R. Fallat. A scholar is included among the top collaborators of R. Fallat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Fallat. R. Fallat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glueck, Charles J., R C Tsang, R. Fallat, & Margot J. Mellies. (1977). Therapy of Familial Hypercholesterolemia in Childhood: Diet and Cholestyramine Resin for 24 to 36 Months. PEDIATRICS. 59(3). 433–441. 25 indexed citations
2.
Glueck, Charles J., et al.. (1977). Hyperalpha- and hypobeta-lipoproteinemia in octogenarian kindreds. Atherosclerosis. 27(4). 387–406. 59 indexed citations
3.
Fallat, R. & Charles J. Glueck. (1976). Familial and acquired type V hyperlipoproteinemia. Atherosclerosis. 23(1). 41–62. 32 indexed citations
4.
Glueck, Charles J., Peter S. Gartside, R. Fallat, Janusz Sielski, & P M Steiner. (1976). Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinemia.. PubMed. 88(6). 941–57. 225 indexed citations
5.
Glueck, Charles J., Peter S. Gartside, R. Fallat, & Soaira Mendoza. (1976). Effect of sex hormones on protamine inactivated and resistant postheparin plasma lipases. Metabolism. 25(6). 625–632. 27 indexed citations
6.
Glueck, Charles J., R. Fallat, Margot J. Mellies, & R C Tsang. (1976). Pediatric Familial Type II Hyperlipoproteinemia: Therapy With Diet and Colestipol Resin. PEDIATRICS. 57(1). 68–74. 19 indexed citations
7.
Glueck, Charles J., R C Tsang, Margot J. Mellies, R. Fallat, & P M Steiner. (1976). Neonatal familial hypobeta-lipoproteinemia. Metabolism. 25(6). 611–614. 10 indexed citations
8.
Mendoza, Soaira, R.F. Lutmer, Charles J. Glueck, et al.. (1976). Composition of HDL-2 and HDL-3 in familial hyperalphalipoproteinemia. Atherosclerosis. 25(1). 131–136. 16 indexed citations
9.
Namboodiri, K.K., Robert C. Elston, Charles J. Glueck, et al.. (1975). Bivariate analyses of cholesterol and triglyceride levels in families in which probands have type IIb lipoprotein phenotype.. PubMed. 27(4). 454–71. 26 indexed citations
10.
Glueck, Charles J., et al.. (1975). Familial hyper-alpha-lipoproteinemia: Studies in eighteen kindreds. Metabolism. 24(11). 1243–1265. 155 indexed citations
11.
12.
Tsang, Reginald C., R. Fallat, & Charles J. Glueck. (1974). Cholesterol at Birth and Age 1: Comparison of Normal and Hypercholesterolemic Neonates. PEDIATRICS. 53(4). 458–470. 59 indexed citations
13.
Ishikawa, Tomohiro, et al.. (1974). COMPARISON OF CAPILLARY AND VENOUS BLOOD SAMPLING FOR QUANTITATION OF PLASMA CHOLESTEROL. Pediatric Research. 8(4). 434–434. 1 indexed citations
14.
Fallat, R. & Charles J. Glueck. (1974). Effects of anabolic and progestational agents upon triglycerides and triglyceride kinetics in normals and hyperlipemic patients. Lipids. 9(2). 117–120. 11 indexed citations
15.
Glueck, Charles J., S. Ford, P M Steiner, Susan T. Buxton, & R. Fallat. (1973). Effects of a progestational oral contraceptive on lipids and lipases. American Journal of Obstetrics and Gynecology. 116(5). 689–693. 12 indexed citations
16.
Fallat, R.. (1973). Suppression of amylase activity by hypertriglyceridemia. JAMA. 225(11). 1331–1334. 24 indexed citations
17.
Glueck, Charles J., S. Ford, P M Steiner, & R. Fallat. (1973). Triglyceride removal efficiency and lipoprotein lipases: Effects of oxandrolone. Metabolism. 22(6). 807–814. 42 indexed citations
18.
Fallat, R.. (1973). Suppression of Amylase Activity by Hypertriglyceridemia. JAMA. 225(11). 1331–1331. 92 indexed citations
19.
Glueck, Charles J., R. Fallat, & Richard Tsang. (1973). PEDIATRIC FAMILIAL TYPE II HYPERLIPOPROTEINEMIA: THERAPY WITH DIET AND CHOLESTYRAMINE RESIN. PEDIATRICS. 52(5). 669–679. 48 indexed citations
20.
Glueck, Charles J., Richard Tsang, William F. Balistreri, & R. Fallat. (1972). Plasma and dietary cholesterol in infancy: Effects of early low or moderate dietary cholesterol intake on subsequent response to increased dietary cholesterol. Metabolism. 21(12). 1181–1192. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026